Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL469P is a human pseudogene derived from reverse transcription and genomic integration of 7SL RNA, the RNA component of the signal recognition particle (SRP)[1][7]. The functional 7SL RNA is essential for co-translational protein targeting and is involved in the SRP ribonucleoprotein complex[3][5]. In contrast, RN7SL469P is one of hundreds of 7SL RNA-like pseudogene loci dispersed in the human genome; it is a truncated, non-functional copy and is not known to encode any protein or to play a canonical biological role[1][7]. Pseudogenes like RN7SL469P may have limited non-coding regulatory potential, but for most 7SL pseudogenes, including this one, no such role has been established[4][7]. This gene is not considered a therapeutic target, receptor, enzyme, transporter, or clinically actionable molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 469, pseudogene (RN7SL469P).